Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells

Abstract

Activation of Stat5 by many cytokines implies that it cannot alone insure the specificity of the regulation of its target genes. We have evidenced a physical and functional interaction between members of two unrelated transcription factor families, Ets-1, Ets-2 and Stat5, which could contribute to the proliferative response to interleukin 2. Competition with GAS- and EBS-specific oligonucleotides and immunoassays with a set of anti-Stat and anti-Ets families revealed that the IL-2-induced Stat5-Ets complex recognizes several GAS motifs identified as target sites for activated Stat5 dimers. Coimmunoprecipitation experiments evidenced that a Stat5/Ets-1/2 complex is formed in vivo in absence of DNA. GST-pull down experiments demonstrated that the C-terminal domain of Ets-1 is sufficient for this interaction in vitro. Cotransfection experiments in Kit225 T cells resulted in cooperative transcriptional activity between both transcription factors in response to a combination of IL-2, PMA and ionomycin. A Stat5-Ets protein complex was the major inducible DNA-binding complex bound to the human IL-2rE GASd/EBSd motif in long-term proliferating normal human T cells activated by CD2 and CD28. These results suggest that the inducible Stat5-Ets protein interaction plays a role in the regulation of gene expression in response to IL-2 in human T lymphocytes.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Anderson MK, Hernandez-Hoyos G, Diamond RA and Rothenberg EV . 1999 Development 126: 3131–3148

  • Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J . 1994 Mol Cell Biol 14: 3230–3241

  • Bassuk AG and Leiden JM . 1997 Adv Immunol 64: 65–104

  • Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM and Cantrell DA . 1994 EMBO J 13: 5605–5615

  • Beadling C, Ng J, Babbage JW and Cantrell DA . 1996 EMBO J 15: 1902–1913

  • Bhat NK, Komschlies KL, Fujiwara S, Fisher RJ, Mathieson BJ, Gregorio TA, Young HA, Kasik JW, Ozato K and Papas TS . 1989 J Immunol 142: 672–678

  • Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A and Livingston DM . 1996 Nature 383: 344–347

  • Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A and Dittmer J . 1999 J Biol Chem 274: 12910–12916

  • Bosselut R, Levin J, Adjadj E and Ghysdael J . 1993 Nucleic Acids Res 21: 5184–5191

  • Boulukos KE, Pognonec P, Rabault B, Begue A and Ghysdael J . 1989 Mol Cell Biol 9: 5718–5721

  • Bradford AP, Conrad KE, Wasylyk C, Wasylyk B and Gutierrez-Hartmann A . 1995 Mol Cell Biol 15: 2849–2857

  • Brown TA and McKnight SL . 1992 Genes Dev 6: 2502–2512

  • Bucher P, Corthesy P, Imbert J and Nabholz M . 1997 Immunobiology 198: 136–143

  • Cantrell DA . 1996 Annu Rev Immunol 14: 259–274

  • Catlett-Falcone R, Dalton WS and Jove R . 1999 Curr Opin Oncol 11: 490–496

  • Cella N, Groner B and Hynes NE . 1998 Mol Cell Biol 18: 1783–1792

  • Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D and Verde P . 1999 Mol Cell Biol 19: 6240–6252

  • Coffer P, de Jonge M, Mettouchi A, Binetruy B, Ghysdael J and Kruijer W . 1994 Oncogene 9: 911–921

  • Costello R, Lipcey C, Algarte M, Cerdan C, Baeuerle PA, Olive D and Imbert J . 1993 Cell Growth Differ 4: 329–339

  • Darnell Jr JE . 1997 Science 277: 1630–1635

  • de la Brousse FC, Birkenmeier EH, King DS, Rowe LB and McKnight SL . 1994 Genes Dev 8: 1853–1865

  • Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L and Finbloom DS . 1997 Blood 90: 1768–1776

  • Gegonne A, Bosselut R, Bailly RA and Ghysdael J . 1993 EMBO J 12: 1169–1178

  • Genuario RR and Perry RP . 1996 J Biol Chem 271: 4388–4395

  • Ghysdael J and Boureux A . 1997 In Yaniv, M and Ghysdael, J eds Oncogenes as Transcriptional Regulators Basel-Boston-Berlin Birkhauser Verlag pp 29–88

  • Giese K, Kingsley C, Kirshner JR and Grosschedl R . 1995 Genes Dev 9: 995–1008

  • Hori T, Uchiyama T, Tsudo M, Umadome H, Ohno H, Fukuhara S, Kita K and Uchino H . 1987 Blood 70: 1069–1072

  • Ihle JN, Nosaka T, Thierfelder W, Quelle FW and Shimoda K . 1997 Stem Cells 15: Suppl 1 105–111

  • Imada K, Bloom ET, Nakajima H, Horvath-Arcidiacono JA, Udy GB, Davey HW and Leonard WJ . 1998 J Exp Med 188: 2067–2074

  • Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G and Thimmapaya B . 1999 J Biol Chem 274: 17342–17352

  • John S, Robbins CM and Leonard WJ . 1996 EMBO J 15: 5627–5635

  • John S, Vinkemeier U, Soldaini E, Darnell JEJ and Leonard WJ . 1999 Mol Cell Biol 19: 1910–1918

  • Kahn-Perles B, Lipcey C, Lecine P, Olive D and Imbert J . 1997 J Biol Chem 272: 21774–21783

  • Lecine P, Algarte M, Rameil P, Beadling C, Bucher P, Nabholz M and Imbert J . 1996 Mol Cell Biol 16: 6829–6840

  • Leonard WJ and O'Shea JJ . 1998 Annu Rev Immunol 16: 293–322

  • Lin JX and Leonard WJ . 1997 Cytokine Growth Factor Rev 8: 313–332

  • Liu X, Robinson GW, Gouilleux F, Groner B and Hennighausen L . 1995 Proc Natl Acad Sci USA 92: 8831–8835

  • Look DC, Pelletier MR, Tidwell RM, Roswit WT and Holtzman MJ . 1995 J Biol Chem 270: 30264–30267

  • Meyer WKH, Reichenbach P, Schindler U, Soldaini E and Nabholz M . 1997 J Biol Chem 272: 31821–31828

  • Miyazaki T and Taniguchi T . 1996 Cancer Surv 27: 25–40

  • Moriggl R, Topham DJ, Teglund S, Sexl V, Mckay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC and Ihle JN . 1999 Immunity 10: 249–259

  • Muhlethaler-Mottet A, Di Berardino W, Otten LA and Mach B . 1998 Immunity 8: 157–166

  • Muthusamy N, Barton K and Leiden JM . 1995 Nature 377: 639–642

  • Nakajima H, Liu XW, Wynshawboris A, Rosenthal LA, Imada K, Finbloom DS, Hennighausen L and Leonard WJ . 1997 Immunity 7: 691–701

  • Olive D, Pages F, Klasen S, Battifora M, Costello R, Nunes J, Truneh A, Ragueneau M, Martin Y, Imbert J, Birg F, Mawas C, Bagnasco M and Cerdan C . 1994 Fundament Clin Immunol 2: 185–197

  • Perez C, Coeffier E, Moreau-Gachelin F, Wietzerbin J and Benech PD . 1994 Mol Cell Biol 14: 5023–5031

  • Pognonec P, Boulukos KE, Gesquiere JC, Stehelin D and Ghysdael J . 1988 EMBO J 7: 977–983

  • Qureshi SA, Salditt-Georgieff M and Darnell Jr JE . 1995 Proc Natl Acad Sci USA 92: 3829–3833

  • Rabault B and Ghysdael J . 1994 J Biol Chem 269: 28143–28151

  • Rabault B, Roussel MF, Tran Quang C and Ghysdael J . 1996 Oncogene 13: 877–881

  • Schaefer TS, Sanders LK and Nathans D . 1995 Proc Natl Acad Sci USA 92: 9097–9101

  • Schaeffer L, Duclert N, Huchet-Dynamus M and Changeux JP . 1998 EMBO J 17: 3078–3090

  • Serdobova I, Pla M, Reichenbach P, Sperisen P, Ghysdael J, Wilson A, Freeman J and Nabholz M . 1997 J Exp Med 185: 1211–1221

  • Shen CH and Stavnezer J . 1998 Mol Cell Biol 18: 3395–3404

  • Sieweke MH, Tekotte H, Frampton J and Graf T . 1996 Cell 85: 49–60

  • Sieweke MH, Tekotte H, Jarosch U and Graf T . 1998 EMBO J 17: 1728–1739

  • Soldaini E, Pla M, Beermann F, Espel E, Corthesy P, Barange S, Waanders GA, MacDonald HR and Nabholz M . 1995 J Biol Chem 270: 10733–10742

  • Stöcklin E, Wissler M, Gouilleux F and Groner B . 1996 Nature 383: 726–728

  • Teglund S, Mckay C, Schuetz E, Vandeursen JM, Stravopodis D, Wang DM, Brown M, Bodner S, Grosveld G and Ihle JN . 1998 Cell 93: 841–850

  • Thomas RS, Tymms MJ, McKinlay LH, Shannon MF, Seth A and Kola I . 1997 Oncogene 14: 2845–2855

  • Thompson CC, Brown TA and McKnight SL . 1991 Science 253: 762–768

  • Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ and Davey HW . 1997 Proc Natl Acad Sci USA 94: 7239–7244

  • Ward SG . 1996 Biochem J 318: 361–377

  • Wasylyk B, Hahn SI and Giovane A . 1993 Eur J Biochem 211: 7–18

  • Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z and Oshima RG . 1998 Genes Dev 12: 1315–1326

  • Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA and Ostrowski MC . 1996 MolCellBiol 16: 538–547

  • Zamorano J, Wang HY, Wang R, Shi Y, Longmore GD and Keegan AD . 1998 J Immunol 160: 3502–3512

  • Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM and Darnell Jr JE . 1996 Proc Natl Acad Sci USA 93: 15092–15096

Download references

Acknowledgements

We thank C Lipcey for excellent technical assistance, Dr P Benech and C Mawas for critical reading of the manuscript. Dr FC De la Brousse, B Groner, SL McKnight and M Sieweke generously provided specific antisera and constructs. This work was supported by the Institut National de la Santé et de la Recherche Médicale and by grants from Association pour la Recherche sur le Cancer, Comité des Bouches-du-Rhône de la Ligue Nationale Contre le Cancer and the European Community Grant CHRX CT 94-0537. It partially fulfils the requirement for the doctoral thesis of P Rameil. P Lecine and P Rameil were supported by fellowships from the Ministère de l'Enseignement Supérieur et de la Recherche and from the Association pour la Recherche sur le Cancer.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rameil, P., Lécine, P., Ghysdael, J. et al. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells. Oncogene 19, 2086–2097 (2000). https://doi.org/10.1038/sj.onc.1203542

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203542

Keywords

This article is cited by

Search

Quick links